Roche Donations and Sponsorship
Web: Roche Donations and Sponsorship
Roche commences tender offer for all shares of Ignyta, Inc. for US$ 27.00 per share in cash Roche today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Ignyta, Inc.
European Commission approves Roche's Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer.
Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer.
Roche launches the cobas Plasma Separation Card to increase access to HIV testing for patients living in remote areas.
Roche announces phase III data showing Venclexta/Venclyxto plus MabThera/Rituxan reduced the risk of disease progression or death by 83% compared to a standard of care regimen in previously treated chronic lymphocytic leukaemia.
Roche to acquire Viewics, Inc.
LinkMedicine and Life Sciences
Last job offers
- Medicine/Pharmacology - 24.2
Wissenschaftliche/r Assistierende/r Pharmazeutische Technologie (80 %)
- Business/Economics - 23.2
Wissenschaftliche(r) Assistent(in) / Doktorand(in)
- Earth Sciences - 22.2
Remote Sensing Scientist – Oceanography (Copernicus) (VN18 12)
- Physics/Materials Science - 22.2
Remote Sensing Scientist for Hyperspectral Infrared Level 1 Processing (VN18 09)
- Life Sciences - 22.2
Wissenschaftliche/n Mitarbeiter/in (50%)
- Chemistry - 21.2
Assistant Professor for Biochemistry with Tenure Track to a position of Full Prof. (Extraordinariat)
- Business/Economics - 20.2
- Pedagogy/Education Science - 20.2
Wissenschaftliche/r Mitarbeiter/in als Data Scientist für intelligente Gebäude (80-100%)